In drug discovery, optimizing ligands—molecules that bind to proteins—is crucial but challenging. Researchers often create hundreds of variations of a molecule to find one with the right properties for use in medicine. A recent study explored how often small, random changes to these molecules lead to significant improvements in their effectiveness. Surprisingly, 11.3% of these minor modifications resulted in a tenfold increase in potency, although they often had poorer pharmacokinetic properties, like how long they last in the body. This research helps set a baseline for what to expect in ligand optimization and highlights the difficulties in improving drug candidates beyond just increasing their potency in lab tests.
QUESTION: How might the challenges in drug optimization impact the development of new medicines for future generations?
